Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Lihui Bai
ID:
1b83bea9-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
20 articles
FDA Approves Johnson & Johnson’s TECVAYLI® plus DARZALEX FASPRO® for the Treatment of Relapsed/Refractory Multiple Myeloma
Big Molecule Watch ·
March 16, 2026
cite
Xbrane Enters into Conditional Financing Deal Related to Ranibizumab Biosimilar
Big Molecule Watch ·
October 24, 2025
cite
Henlius Receives Orphan-Drug Designation for HLX22 (anti-HER2 mAb) for Gastric Cancer
Big Molecule Watch ·
March 28, 2025
cite
Bio-Thera and Gedeon Richter Reach Exclusive Commercialization Agreement for Ustekinumab Biosimilar
Big Molecule Watch ·
October 30, 2024
cite
Alteogen Seeks Approval for Aflibercept Biosimilar in Korea
Big Molecule Watch ·
September 18, 2024
cite
Previous
1
2
3
4
Next
